Related Experiment Video
Updated: Oct 19, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
The Hippo pathway: an emerging role in urologic cancers
Bekir Cinar1, Esma Alp1, Marwah Al-Mathkour1
1The Center for Cancer Research and Therapeutic Development, Department of Biological Sciences, Clark Atlanta University Atlanta, Georgia, USA.
Abstract:
The Hippo pathway controls several biological processes, including cell growth, differentiation, motility, stemness, cell contact, immune cell maturation, organ size, and tumorigenesis. The Hippo pathway core kinases MST1/2 and LATS1/2 in mammals phosphorylate and inactivate YAP1 signaling. Increasing evidence indicates that loss of MST1/2 and LATS1/2 function is linked to the biology of many cancer types with poorer outcomes, likely due to the activation of oncogenic YAP1/TEAD signaling. Therefore, there is a renewed interest in blocking the YAP1/TEAD functions to prevent cancer growth. This review introduces the Hippo pathway components and examines their role and therapeutic potentials in prostate, kidney, and bladder cancer.
Insights
The Hippo pathway regulates cell growth and organ size. Inhibiting YAP1/TEAD signaling, often dysregulated in cancers like prostate, kidney, and bladder, offers therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Hippo pathway is a crucial regulator of cell proliferation, differentiation, and organ size.
- Core kinases MST1/2 and LATS1/2 inactivate YAP1 signaling.
- Dysregulation of the Hippo pathway, particularly YAP1/TEAD signaling, is implicated in various cancers.
Purpose of the Study:
- To review the components of the Hippo pathway.
- To examine the role of the Hippo pathway in prostate, kidney, and bladder cancers.
- To explore the therapeutic potential of targeting YAP1/TEAD signaling in these cancers.
Main Methods:
- Literature review of Hippo pathway components.
- Analysis of Hippo pathway involvement in genitourinary cancers.
- Evaluation of therapeutic strategies targeting YAP1/TEAD.
Main Results:
- Loss of MST1/2 and LATS1/2 function correlates with cancer progression.
- Activated YAP1/TEAD signaling contributes to oncogenesis in these cancers.
- Targeting YAP1/TEAD presents a promising therapeutic avenue.
Conclusions:
- The Hippo pathway is vital in controlling cellular processes and organ development.
- Aberrant YAP1/TEAD signaling drives tumorigenesis in prostate, kidney, and bladder cancers.
- Inhibiting YAP1/TEAD signaling holds significant therapeutic promise for treating these malignancies.
Related Concept Videos
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Regulation of Angiogenesis and Blood Supply

